134 related articles for article (PubMed ID: 18538738)
21. Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor beta, and c-Kit, in patients with advanced or metastatic solid tumors.
Eskens FA; Steeghs N; Verweij J; Bloem JL; Christensen O; van Doorn L; Ouwerkerk J; de Jonge MJ; Nortier JW; Kraetzschmar J; Rajagopalan P; Gelderblom H
J Clin Oncol; 2009 Sep; 27(25):4169-76. PubMed ID: 19636022
[TBL] [Abstract][Full Text] [Related]
22. Lymphangiogenesis in kidney cancer: expression of VEGF-C, VEGF-D and VEGFR-3 in clear cell and papillary renal cell carcinoma.
Bierer S; Herrmann E; Köpke T; Neumann J; Eltze E; Hertle L; Wülfing C
Oncol Rep; 2008 Oct; 20(4):721-5. PubMed ID: 18813809
[TBL] [Abstract][Full Text] [Related]
23. Integrin β4 Is an Effective and Efficient Marker in Synchronously Highlighting Lymphatic and Blood Vascular Invasion, and Perineural Aggression in Malignancy.
Li J; Jiang Y; Chen C; Tan W; Li P; Chen G; Peng Q; Yin W
Am J Surg Pathol; 2020 May; 44(5):681-690. PubMed ID: 32044807
[TBL] [Abstract][Full Text] [Related]
24. Expression of the hyaluronan receptor LYVE-1 is not restricted to the lymphatic vasculature; LYVE-1 is also expressed on embryonic blood vessels.
Gordon EJ; Gale NW; Harvey NL
Dev Dyn; 2008 Jul; 237(7):1901-9. PubMed ID: 18570254
[TBL] [Abstract][Full Text] [Related]
25. Peptide targeting of tumor lymph vessels.
Laakkonen P; Zhang L; Ruoslahti E
Ann N Y Acad Sci; 2008; 1131():37-43. PubMed ID: 18519957
[TBL] [Abstract][Full Text] [Related]
26. The lymphatic system and its specific growth factor vascular endothelial growth factor C in kidney tissue and in renal cell carcinoma.
Voss M; Steidler A; Grobholz R; Weiss C; Alken P; Michel MS; Trojan L
BJU Int; 2009 Jul; 104(1):94-9. PubMed ID: 19500329
[TBL] [Abstract][Full Text] [Related]
27. Sox18 induces development of the lymphatic vasculature in mice.
François M; Caprini A; Hosking B; Orsenigo F; Wilhelm D; Browne C; Paavonen K; Karnezis T; Shayan R; Downes M; Davidson T; Tutt D; Cheah KS; Stacker SA; Muscat GE; Achen MG; Dejana E; Koopman P
Nature; 2008 Dec; 456(7222):643-7. PubMed ID: 18931657
[TBL] [Abstract][Full Text] [Related]
28. Expression of thymosin beta10 and its role in non-small cell lung cancer.
Gu Y; Wang C; Wang Y; Qiu X; Wang E
Hum Pathol; 2009 Jan; 40(1):117-24. PubMed ID: 18789485
[TBL] [Abstract][Full Text] [Related]
29. Remodeling retinal neovascularization by ALK1 gene transfection in vitro.
Li B; Yin W; Hong X; Shi Y; Wang HS; Lin SF; Tang SB
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4553-60. PubMed ID: 18829861
[TBL] [Abstract][Full Text] [Related]
30. Transient receptor potential canonical type 3 channels and blood pressure in humans.
Thilo F; Baumunk D; Krause H; Schrader M; Miller K; Loddenkemper C; Zakrzewicz A; Krueger K; Zidek W; Tepel M
J Hypertens; 2009 Jun; 27(6):1217-23. PubMed ID: 19417689
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical endothelial markers: a review.
Ordóñez NG
Adv Anat Pathol; 2012 Sep; 19(5):281-95. PubMed ID: 22885378
[TBL] [Abstract][Full Text] [Related]
32. TLR4 signaling promotes the expression of VEGF and TGFbeta1 in human prostate epithelial PC3 cells induced by lipopolysaccharide.
Pei Z; Lin D; Song X; Li H; Yao H
Cell Immunol; 2008; 254(1):20-7. PubMed ID: 18649875
[TBL] [Abstract][Full Text] [Related]
33. The role of RhoC in growth and metastatic capacity of melanoma.
Boone B; Van Gele M; Lambert J; Haspeslagh M; Brochez L
J Cutan Pathol; 2009 Jun; 36(6):629-36. PubMed ID: 19222696
[TBL] [Abstract][Full Text] [Related]
34. Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma.
Mannelqvist M; Stefansson I; Salvesen HB; Akslen LA
Histopathology; 2009 Jan; 54(2):174-83. PubMed ID: 19207942
[TBL] [Abstract][Full Text] [Related]
35. Co-expression of receptor tyrosine kinases in esophageal adenocarcinoma and squamous cell cancer.
Gockel I; Moehler M; Frerichs K; Drescher D; Trinh TT; Duenschede F; Borschitz T; Schimanski K; Biesterfeld S; Herzer K; Galle PR; Lang H; Junginger T; Schimanski CC
Oncol Rep; 2008 Oct; 20(4):845-50. PubMed ID: 18813825
[TBL] [Abstract][Full Text] [Related]
36. Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: correlation with clinical parameters and outcome.
Mouawad R; Spano JP; Comperat E; Capron F; Khayat D
Eur J Cancer; 2009 May; 45(8):1407-14. PubMed ID: 19157860
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of vascular endothelial growth factor-C and its receptor in the rat hippocampus following transient forebrain ischemia.
Shin YJ; Choi JS; Lee JY; Choi JY; Cha JH; Chun MH; Lee MY
Acta Neuropathol; 2008 Nov; 116(5):517-27. PubMed ID: 18704465
[TBL] [Abstract][Full Text] [Related]
38. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
39. Differential proteomic analysis of lymphatic, venous, and arterial endothelial cells extracted from bovine mesenteric vessels.
Nguyen VP; Hanna G; Rodrigues N; Pizzuto K; Yang E; Van Slyke P; Kim H; Chen SH; Dumont DJ
Proteomics; 2010 Apr; 10(8):1658-72. PubMed ID: 20186751
[TBL] [Abstract][Full Text] [Related]
40. Involvement of LYVE-1-positive endothelial cells in the formation of non-lymphatic vascular malformations.
Boettcher MC; Eivazi B; Roessler M; Bette M; Cai C; Wiegand S; Güldner C; Werner JA; Mandic R
Histopathology; 2010 Nov; 57(5):764-8. PubMed ID: 21083607
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
